Procyrion Announces First Patient Enrollments in the DRAIN-HF Pivotal IDE Trial for Aortix Percutaneous Mechanical Circulatory Support Technology
Technology to be evaluated in acute decompensated heart failure patients, where current treatment options remain ineffective and lacking
Source: dicardiology.com